Introduction
Streptococcus suis is a zoonotic pathogen that can be transferred from pigs to humans, including humans (with or without wounds) who handle raw pork or have close contact with infected pigs (e.g., pig farmers). Serotypes 2 and 14 are prevalent among patients with S. suis infections, although other serotypes (1, 4, 5, 16 , and 24) have been detected in rare human cases. Kerdsin et al. [1] screened among 179 human S. suis strains isolated from clinical specimens in Thailand (2006 Thailand ( -2008 and reported that 165 (92.2%) and 12 (6.7%) strains were of serotype 2 and 14, respectively, whereas only one (0.6%) each was of serotype 5 and 24 [2] . We herein report a human case of uncomplicated bacteremia due to S. suis serotype 5 in Japan. Furthermore, we provide the review of literature concerning clinical and microbiological characteristics of 4 human cases of infection due to S. suis serotype 5.
Case report
A 48-year-old man was admitted to our hospital with fever, rigors, and swelling of the right forefinger. The patient was a heavy user of alcohol without the underlying liver disease who had been working for a kushiyaki (meat skewer restaurant), a job that included handling raw pork with his bare hands and occasional accidental stabbing of a finger with a skewer. Two days before visiting our hospital, this individual had deeply stabbed his right forefinger with a skewer. On arrival in the emergency room, the patient had a body temperature of 39. 4 C, and exhibited no neck stiffness or meningism, nor peripheral stigmata of infective endocarditis; precordial examination revealed no audible cardiac murmur. Leukocyte cell count and C-reactive protein were 8200/ mL and 0.40 mg/dL, respectively.
After admission, blood culture by duplicate bottles revealed the presence of gram-positive cocci. Given the patient's routine handling of raw pork, infection by S. suis was suspected; this species identification was confirmed based on percent probability (98.9%) match to biochemical parameters obtained using Rapid ID 32 Strep API (SYSMEX bioMérieux Co., Ltd., Tokyo, Japan). The isolate was stored at À80 C pending further characterization. A transesophageal echocardiography, a computed tomography of the chest-abdomen-pelvis, and a magnetic resonance imaging of the brain failed to reveal evidence of infective foci. Therefore, the patient was diagnosed with uncomplicated bacteremia due to S. suis, and was treated with a 2-week course of penicillin G (8 million units, three times per day, daily dose 24 million units). Treatment was successful; the patient remained well, with no recurrence of bacteremia, during 12 months of follow up.
This speciation was further confirmed based on 99.86% (1415/ 1417 bp) sequence identity to S. suis S735 (T), in addition to amplification of species-specific glutamate dehydrogenase gene from the patient isolate [3] . Polymerase chain reaction (PCR)-based capsular typing demonstrated that the isolate was of serotype 5 [3] . Multilocus sequence typing (MLST) was performed by sequencing 7 housekeeping genes (aroA-cpn60-dpr-gki-mutSrecA-thrA) according to the website for S. suis (http://pubmlst. org/ssuis/); our results revealed the presence of a novel sequence type (ST) 752 [allelic profile, 8-21-5-264(new allele)-44-22-23] for this strain. Virulence-associated gene (VAG) profiling was performed as previously described [4] ; both sly (encoding the hemolysin suilysin) and mrp (encoding a muramidase-released protein) were detected without amplification of epf (encoding the extracellular factor). Furthermore, antimicrobial testing suggested that the isolate would be classified as resistance to tetracycline (TC) and macrolide/lincosamide (ML) (clarithromycin and clindamycin). Note, however, that these classifications employed the breakpoints for viridans group streptococci, since the Clinical and Laboratory Standards Institute guidelines do not provide breakpoints for S. suis. Our PCR-based results indicated that this isolate possessed both tet(O), the TC-resistance determinant, and erm(B), the ML-resistance determinant [5, 6] .
Discussion
Strains of serotype 5 are routinely isolated from diseased pigs [7] . According to the MLST database, the porcine-linked serotype 5 isolates have been reported from UK, Denmark, China, Vietnam, and Poland. Clinical and microbiological features of four human cases of S. suis serotype 5 infections are shown in Tables 1 and 2 . Three previous patients infected with the serotype 5 strains have been documented: a patient eating raw pork who developed spontaneous bacterial peritonitis in Thailand [2] , a pig farmer with the wound who developed septic arthritis in Sweden [8] , and a pig farmer without the wound who developed arthroplasty infection and streptococcal toxic shock-like syndrome in the US [9] . Spontaneous bacterial peritonitis due to the other serotypes [10, 11] as well as the arthritis and the streptococcal toxic shock syndrome are already documented. On the other hand, to our knowledge, this is the first report on the arthroplasty infection associated with the serotype 5. We should further clarify the relationship between the arthroplasty infection and this serotype, based on the collection of human cases and the literature review. To the best of our knowledge, the present patient handling with raw pork is the first human case of uncomplicated bacteremia due to serotype 5 in Japan.
Because most of human S. suis infections are associated with clonal complex (CC) 1 strains including ST1 strains [12] , CC1 strains are considered to be the most hazardous ones for humans. CC1 strains have been frequently isolated from diseased pigs in Resistance of S. suis to antimicrobials (macrolide/lincosamide, sulphonamides, and tetracycline) commonly used in pigs is documented worldwide, with resistance in up to 85% of strains [13] . Bojarska and the colleagues [12] have reported that five isolates (24%) of 21 invasive human infections were nonsusceptible to ML and TC, and harbored the tet(O) and erm(B) genes. Therefore, resistance should be considered when any of these classes are not effective in human clinical settings.
In conclusion, clinicians should be aware of this microorganism when examining and treating patients with fever, who are handling raw pork or having close contact with infected pigs even if they are immunocompetent.
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